Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BSGM Biosig Technologies	$4.95 +3.5%	$5.88	$0.23 ▼ $14.11	$155.37M	1.65	699,290 shs	441,565 shs
ELMD Electromed	$24.58 -0.8%	$19.73	$15.06 ▼ $35.56	$205.12M	0.38	83,865 shs	89,491 shs
MBOT Microbot Medical	$4.00 -1.8%	$2.81	$0.82 ▼ $4.62	$182.43M	1.15	3.14 million shs	1.90 million shs
MLSS Milestone Scientific	$0.60 -0.1%	$0.63	$0.38 ▼ $1.39	$46.43M	0.8	209,156 shs	34,201 shs

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BSGM Biosig Technologies	-9.30%	+1.27%	+4.60%	-5.35%	+1,094.70%
ELMD Electromed	+19.89%	+26.31%	+31.55%	+21.36%	+54.33%
MBOT Microbot Medical	+4.90%	+22.96%	+40.34%	+51.87%	+315.65%
MLSS Milestone Scientific	-1.63%	-0.12%	+22.60%	-37.46%	-40.27%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BSGM Biosig Technologies	2.6274 of 5 stars	3.5	0.0	3.3	1.7	0.6
ELMD Electromed	2.3593 of 5 stars	3.7	3.0	2.0	1.7	0.0
MBOT Microbot Medical	1.5454 of 5 stars	3.3	1.0	2.9	0.0	0.6
MLSS Milestone Scientific	2.389 of 5 stars	3.5	3.0	0.0	2.5	0.0

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BSGM Biosig Technologies	3.00	Buy	$10.00	102.22% Upside
ELMD Electromed	3.33	Buy	$36.25	47.45% Upside
MBOT Microbot Medical	2.50	Moderate Buy	$9.00	125.28% Upside
MLSS Milestone Scientific	3.00	Buy	$1.25	109.38% Upside

Current Analyst Ratings Breakdown

Latest MLSS, MBOT, ELMD, and BSGM Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/27/2025	ELMD Electromed	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$36.00
8/27/2025	ELMD Electromed	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$29.00 ➝ $35.00
8/27/2025	ELMD Electromed	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$36.00
8/21/2025	MBOT Microbot Medical	Zacks Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
7/22/2025	ELMD Electromed	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$29.00
7/21/2025	ELMD Electromed	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
6/6/2025	BSGM Biosig Technologies	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$2.50 ➝ $10.00

(Data available from 8/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BSGM Biosig Technologies	$40K	3,884.30	N/A	N/A	($0.11) per share	-44.95
ELMD Electromed	$61.44M	3.36	$0.59 per share	41.36	$5.10 per share	4.82
MBOT Microbot Medical	N/A	N/A	N/A	N/A	$0.67 per share	N/A
MLSS Milestone Scientific	$9.08M	5.16	N/A	N/A	$0.11 per share	5.43

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BSGM Biosig Technologies	-$10.33M	N/A	0.00	N/A	N/A	N/A	-5,336.99%	-90.03%	11/13/2025 (Estimated)
ELMD Electromed	$5.15M	$0.79	32.61	∞	N/A	11.34%	15.71%	13.37%	N/A
MBOT Microbot Medical	-$11.44M	-$0.58	N/A	N/A	N/A	N/A	-76.27%	-67.54%	11/12/2025 (Estimated)
MLSS Milestone Scientific	-$6.93M	-$0.09	N/A	∞	N/A	-52.01%	-60.26%	-40.23%	N/A

Latest MLSS, MBOT, ELMD, and BSGM Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/15/2025	Q2 2025	BSGM Biosig Technologies	-$0.04	-$0.74	-$0.70	-$0.74	N/A	N/A
8/12/2025	Q2 2025	MBOT Microbot Medical	-$0.08	-$0.10	-$0.02	-$0.10	$1.00 million	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BSGM Biosig Technologies	N/A	N/A	N/A	N/A	N/A
ELMD Electromed	N/A	N/A	N/A	N/A	N/A
MBOT Microbot Medical	N/A	N/A	N/A	N/A	N/A
MLSS Milestone Scientific	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BSGM Biosig Technologies	N/A	0.03	0.03
ELMD Electromed	N/A	5.10	4.74
MBOT Microbot Medical	N/A	12.06	12.06
MLSS Milestone Scientific	N/A	2.85	1.86

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BSGM Biosig Technologies	7.16%
ELMD Electromed	40.82%
MBOT Microbot Medical	16.30%
MLSS Milestone Scientific	5.79%

Insider Ownership

Company	Insider Ownership
BSGM Biosig Technologies	24.80%
ELMD Electromed	14.00%
MBOT Microbot Medical	4.74%
MLSS Milestone Scientific	24.75%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BSGM Biosig Technologies	50	31.42 million	23.63 million	No Data
ELMD Electromed	160	8.39 million	7.36 million	Optionable
MBOT Microbot Medical	20	45.55 million	43.39 million	Optionable
MLSS Milestone Scientific	30	78.56 million	58.61 million	Optionable

MLSS, MBOT, ELMD, and BSGM Headlines

Recent News About These Companies

Milestone Scientific, Inc.: Milestone Scientific Achieves 25% Increase in Revenue for the Second Quarter of 2025

August 16, 2025 | finanznachrichten.de

Milestone Scientific Achieves 25% Increase in Revenue for the Second Quarter of 2025

August 14, 2025 | globenewswire.com

Milestone Scientific Schedules Second Quarter 2025 Financial Results and Business Update Conference Call

August 13, 2025 | globenewswire.com

Milestone Scientific Appoints Jason Papes as Senior Vice President, Global Head of Sales and Marketing

August 6, 2025 | globenewswire.com

Milestone Scientific Appoints Eric C. Hines as Chief Executive Officer

August 1, 2025 | globenewswire.com

Milestone Scientific Commences Sales of CompuFlo® Epidural System at The Painless Center in Tenafly, New Jersey

July 17, 2025 | globenewswire.com

S.R.L. Bp4 Sells 30,558 Shares of Milestone Scientific Inc. (NYSE:MLSS) Stock

July 11, 2025 | insidertrades.com

MLSS Milestone Scientific Inc. - Seeking Alpha

June 27, 2025 | seekingalpha.com

Milestone Scientific Inc. (MLSS) - Yahoo Finance

June 27, 2025 | finance.yahoo.com

S.R.L. Bp4 Sells 23,797 Shares of Milestone Scientific Inc. (NYSE:MLSS) Stock

June 17, 2025 | insidertrades.com

Kalkine : NYSE Composite Sees MLSS Movement Amid Light Trading Volume

June 10, 2025 | kalkinemedia.comK

Milestone Scientific Inc. (NYSE:MLSS) Major Shareholder S.R.L. Bp4 Sells 14,256 Shares

May 31, 2025 | insidertrades.com

Milestone Scientific Appoints Highly Accomplished MedTech Executive Shanth Thiyagalingam to Board of Directors

May 19, 2025 | globenewswire.com

Milestone Scientific, Inc.: Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2025

May 17, 2025 | finanznachrichten.de

Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2025

May 16, 2025 | manilatimes.netM

Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2025

May 15, 2025 | globenewswire.com

Why Milestone Scientific Inc.’s (MLSS) Stock Is Down 5.50%

May 5, 2025 | aaii.comA

Milestone Scientific Reports Year-End 2024 Financial Results and Reports Strong Outlook for 2025

April 15, 2025 | markets.businessinsider.com

Why Milestone Scientific Inc.’s (MLSS) Stock Is Up 7.95%

April 9, 2025 | aaii.comA

Why Milestone Scientific Inc.’s (MLSS) Stock Is Up 10.53%

April 2, 2025 | aaii.comA

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

MLSS, MBOT, ELMD, and BSGM Company Descriptions

Biosig Technologies NASDAQ:BSGM

$4.94 +0.17 (+3.45%)

As of 03:52 PM Eastern

BioSig Technologies, Inc., together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

Electromed NYSE:ELMD

$24.58 -0.19 (-0.75%)

As of 03:53 PM Eastern

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

Microbot Medical NASDAQ:MBOT

$4.00 -0.08 (-1.84%)

As of 03:53 PM Eastern

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.

Milestone Scientific NYSE:MLSS

$0.60 0.00 (-0.05%)

As of 03:53 PM Eastern

Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. In addition, the company offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. Further, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Additionally, the company offers company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time